Concepedia

Peter S. Goedegebuure

PS

Statistics

Publications

71

Citations

7.6K

H-Index

36

Active since

1990

Affiliations

Washington University in St. Louis(Current)

Brigham and Women's Hospital

Harvard University

Alvin J. Siteman Cancer Center

Jewish Hospital

Peter S. Goedegebuure is an author at Washington University in St. Louis specializing in oncology, immunology, and cancer immunology.

Publications per year

1990–2019

71

Publications

71

Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma

Udaya Liyanage, Todd T. Moore, Hong‐Gu Joo et al. · The Journal of Immunology · 2002 · 1.5K citations

Life Sciences, Immunology, Oncology +13

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff et al. · Cancer Research · 2012 · 941 citations

Medicine, Immunology, Oncology +15

Targeting both tumour-associated CXCR2<sup>+</sup> neutrophils and CCR2<sup>+</sup> macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

Timothy M. Nywening, Brian A. Belt, Darren R. Cullinan et al. · Gut · 2017 · 481 citations · Full text

Medicine, Immunology, Oncology +17

Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer

Marcus Tan, Peter S. Goedegebuure, Brian A. Belt et al. · The Journal of Immunology · 2009 · 450 citations · Full text

Medicine, Immunology, Oncology +14

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

George E. Peoples, Peter S. Goedegebuure, Robert W. Smith et al. · Proceedings of the National Academy of Sciences · 1995 · 440 citations

Life Sciences, Immunology, Oncology +17

1–5 of 71